Depreciation
Merck & Co. Depreciation decreased by 61.1% to $581.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 15.7%, from $502.00M to $581.00M. Over 4 years (FY 2021 to FY 2025), Depreciation shows an upward trend with a 17.9% CAGR.
Analysis
How to read this metric
Higher depreciation relative to capital expenditures may suggest aging assets, while lower levels relative to revenue may indicate high asset efficiency.
Detailed definition
Depreciation is a non-cash accounting charge that allocates the cost of tangible assets over their useful lives. It refl...
Peer comparison
Standardized for capital-intensive industries; peers in manufacturing typically show significant depreciation expenses.
operating_depreciationHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $371.00M | $399.00M | $430.00M | $421.00M | $474.00M | $499.00M | $430.00M | $448.00M | $426.00M | $452.00M | $502.00M | $511.00M | $518.00M | $553.00M | $522.00M | $502.00M | $518.00M | $532.00M | $1.49B | $581.00M |
| QoQ Change | — | +7.5% | +7.8% | -2.1% | +12.6% | +5.3% | -13.8% | +4.2% | -4.9% | +6.1% | +11.1% | +1.8% | +1.4% | +6.8% | -5.6% | -3.8% | +3.2% | +2.7% | +180.6% | -61.1% |
| YoY Change | — | — | — | — | +27.8% | +25.1% | +0.0% | +6.4% | -10.1% | -9.4% | +16.7% | +14.1% | +21.6% | +22.3% | +4.0% | -1.8% | +0.0% | -3.8% | +186.0% | +15.7% |
Business Segments
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Animal Health | $67.00M | $85.00M | $45.00M | $60.00M | $62.00M | $82.00M | $79.00M | $89.00M |
| Pharmaceutical | $1.00M | $1.00M | $2.00M | $1.00M | $1.00M | $1.00M | $1.00M | $1.00M |
| Total | $518.00M | $553.00M | $522.00M | $502.00M | $518.00M | $532.00M | $1.49B | $581.00M |
Animal Health, Pharmaceutical were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.
Depreciation at Other Companies
Frequently Asked Questions
- What is Merck & Co.'s depreciation?
- Merck & Co. (MRK) reported depreciation of $581.00M in Q1 2026.
- How has Merck & Co.'s depreciation changed year-over-year?
- Merck & Co.'s depreciation increased by 15.7% year-over-year, from $502.00M to $581.00M.
- What is the long-term trend for Merck & Co.'s depreciation?
- Over 4 years (2021 to 2025), Merck & Co.'s depreciation has grown at a 17.9% compound annual growth rate (CAGR), from $1.58B to $3.05B.
- What does depreciation mean?
- The systematic reduction in the recorded value of physical assets over time.